Experimental therapeutics in hereditary neuropathies: The past, the present, and the future
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Link
http://www.springerlink.com/index/pdf/10.1016/j.nurt.2008.07.001
Reference51 articles.
1. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981;10: 222–226.
2. Nicholson GA. The dominantly inherited motor and sensory neuropathies: clinical and molecular advances. Muscle Nerve 2006;33: 589–597.
3. Saifi GM, Szigeti K, Snipes GJ, Garcia CA, Lupski JR. Molecular-mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies [Erratum in: J Investig Med 2004;52:50]. J Investig Med 2003;51: 261–283.
4. Shy ME. Therapeutic strategies for the inherited neuropathies. Neuromolecular Med 2006;8: 255–278.
5. Sackley C, Disler PB, Tumer-Stokes L, Wade DT. Rehabilitation interventions for foot drop in neuromuscular disease. Cochrane Database Syst Rev 2007;(2):CD003908.
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives;Neurobiology of Disease;2024-04
2. Case report: A novel variant (H49N) in Myelin Protein Zero gene is responsible for a patient with Charcot–Marie–Tooth disease;Frontiers in Neurology;2024-02-28
3. Genetic approaches and pathogenic pathways in the clinical management of Charcot-Marie-Tooth disease;Journal of Translational Genetics and Genomics;2022
4. Mitochondrial Dynamics: Molecular Mechanisms, Related Primary Mitochondrial Disorders and Therapeutic Approaches;Genes;2021-02-10
5. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS);Expert Opinion on Therapeutic Targets;2020-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3